Apogee Therapeutics, Inc. Common Stock (APGE) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for APGE. 13F holdings as of 2026-03-31.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 10,300,984 | $867M | INCREASED |
| FMR LLC | 9,262,291 | $780M | INCREASED |
| Venrock Adviser, LLC | 8,493,321 | $715M | UNCHANGED |
| WELLINGTON MANAGEMENT GROUP LLP | 4,375,703 | $368M | DECREASED |
| BlackRock, Inc. | 4,085,651 | $344M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Michael Thomas Henderson (Chief Executive Officer) | SELL | 80,000 | $11M | 2026-06-22 |
| Carl Dambkowski (Chief Medical Officer) | SELL | 26,400 | $4M | 2026-06-22 |
| Michael Thomas Henderson (Chief Executive Officer) | SELL | 614 | $53K | 2026-06-10 |
| Michael Thomas Henderson (Chief Executive Officer) | SELL | 2,305 | $199K | 2026-06-10 |
| Michael Thomas Henderson (Chief Executive Officer) | SELL | 1,577 | $134K | 2026-06-10 |
Full institutional holdings, insider history, and congressional trades for Apogee Therapeutics, Inc. Common Stock on SentiSense.